Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/01/22
End: 06/17/24
Due: 06/17/25
Phase: N/A
Priority: Normal
Start: 06/30/23
End: 08/27/24
Due: 08/27/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Advanced Solid Tumors | NCT05501912 | ABM Therapeutics Shanghai Company Limited | user2@example.com | None | 2022-09-01 | 2024-06-17 | 2025-06-17 | - | - | 2025-07-14 |
| A Study of ABM-1310 in Patients With BRAF V600-Mutant Relapsed and Drug Resistant Primary Malignant Brain Tumors | NCT05892653 | ABM Therapeutics Shanghai Company Limited | user2@example.com | None | 2023-06-30 | 2024-08-27 | 2025-08-27 | - | - | 2025-07-14 |